Diffuse Large B-Cell Lymphoma/High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Study of 60 Cases
Authors:
- 11 January 2025
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 38 (5) , 100710
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potentialLeukemia, 2024
- A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classificationsBlood Cancer Journal, 2023
- High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCLLeukemia, 2022
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid NeoplasmsLeukemia, 2022
- Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hitLeukemia, 2019
- MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomasLaboratory Investigation, 2018
- Functional Implications of the spectrum of BCL2 mutations in LymphomaMutation Research - Reviews in Mutation Research, 2016
- Impact of oncogene rearrangement patterns on outcomes in patients with double‐hit non‐Hodgkin lymphomaCancer, 2015
- B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcomeLaboratory Investigation, 2011
- The c-Myc target gene networkSeminars in Cancer Biology, 2006